The Impact of COVID-19 on the Tuberculosis Features in a Romanian Pneumology Hospital

References

• World Health Organization. Global tuberculosis report 2022; 2022. Available from: https://iris.who.int/bitstream/handle/10665/363752/9789240061729-eng.pdf?sequence=1. Accessed 11, December 2023.
   Google Scholar
• Cioboata R, Biciusca V, Olteanu M, Vasile CM. COVID-19 and Tuberculosis: unveiling the Dual Threat and Shared Solutions Perspective. J Clin Med. 2023;12:4784. doi:10.3390/jcm12144784
   PubMed Web of Science ®Google Scholar
• Gibson PG, Qin L, Puah SH. COVID-19 acute respiratory distress syndrome (ARDS): clinical features and differences from typical pre-COVID-19 ARDS. Med J Aust. 2020;213(2):54–56.e51. doi:10.5694/mja2.50674
   PubMed Web of Science ®Google Scholar
• Mocanu AI, Mocanu H, Moldovan C, et al. Some Manifestations of Tuberculosis in Otorhinolaryngology - Case Series and a Short Review of Related Data from South-Eastern Europe. Infect Drug Resist. 2022;15:2753–2762. doi:10.2147/IDR.S367885
   PubMed Web of Science ®Google Scholar
• Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and Respiratory System Disorders: current Knowledge, Future Clinical and Translational Research Questions. Arterioscler Thromb Vasc Biol. 2020;40(11):2586–2597. doi:10.1161/ATVBAHA.120.314515
   PubMed Web of Science ®Google Scholar
• Visca D, Ong CWM, Tiberi S, et al. Tuberculosis and COVID-19 interaction: a review of biological, clinical and public health effects. Pulmonology. 2021;27(2):151–165. doi:10.1016/j.pulmoe.2020.12.012
   PubMed Web of Science ®Google Scholar
• Al Maqbali M, Al Badi K, Al Sinani M, Madkhali N, Dickens GL. Clinical Features of COVID-19 Patients in the First Year of Pandemic: a Systematic Review and Meta-Analysis. Biol Res Nurs. 2022;24(2):172–185. doi:10.1177/10998004211055866
   PubMed Web of Science ®Google Scholar
• Biswas SS, Awal SS, Awal SK. COVID-19 and pulmonary tuberculosis - A diagnostic dilemma. Radiol Case Rep. 2021;16(11):3255–3259. doi:10.1016/j.radcr.2021.07.079
   PubMedGoogle Scholar
• Vasile MC, Arbune AA, Lupasteanu G, Vlase CM, Popovici GC, Arbune M. Epidemiologic and Clinic Characteristics of the First Wave of the COVID-19 Pandemic in Hospitalized Patients from Galați County. J Clin Med. 2021;10:18. doi:10.3390/jcm10184210
   Web of Science ®Google Scholar
• Kumar R, Rai AK, Phukan MM, et al. Accumulating Impact of Smoking and Co-morbidities on Severity and Mortality of COVID-19 Infection: a Systematic Review and Meta-analysis. Curr Genomics. 2021;22(5):339–352. doi:10.2174/1389202922666210921101728
   PubMed Web of Science ®Google Scholar
• Vidyasagaran AL, Readshaw A, Boeckmann M, et al. Is Tobacco Use Associated With Risk of Recurrence and Mortality Among People With TB?: a Systematic Review and Meta-Analysis. Chest. 2024;165(1):22–47. doi:10.1016/j.chest.2023.08.021
   PubMed Web of Science ®Google Scholar
• Herrera MT, Guzmán-Beltrán S, Bobadilla K, et al. Human Pulmonary Tuberculosis: understanding the Immune Response in the Bronchoalveolar System. Biomolecules. 2022;12(8). doi:10.3390/biom12081148
   Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis Surveillance and Monitoring in Europe 2022 – 2020 Data. Copenhagen: WHO Regional Office for Europe and Stockholm: European Centre for Disease Prevention and Control; 2022.
   Google Scholar
• Patra K, Batabyal S, Mandal K, Ghose D, Sarkar J. Tuberculosis and COVID-19: a combined global threat to human civilization. Clin Epidemiol Glob Health. 2022;15:101031. doi:10.1016/j.cegh.2022.101031
   PubMed Web of Science ®Google Scholar
• Gong W, Mao Y, Li Y, Qi Y. BCG Vaccination: a potential tool against COVID-19 and COVID-19-like Black Swan incidents. Int Immunopharmacol. 2022;108:108870. doi:10.1016/j.intimp.2022.108870
   PubMed Web of Science ®Google Scholar
• Harries AD, Kumar AMV, Satyanarayana S. TB and COVID-19: measuring key risk factors that affect treatment outcomes. Int J Tubercul Lung Dis. 2021;25(4):329–331. doi:10.5588/IJTLD.21.0061
   PubMed Web of Science ®Google Scholar
• MINISTERUL SĂNĂTĂȚII ORDIN nr. 956 din 31 martie 2022 privind modificarea Ordinului ministrului sănătății nr. 1.171/2015 pentru aprobarea unor reglementări privind controlul tuberculozei: GHID METODOLOGIC DE IMPLEMENTARE A PROGRAMULUI NAŢIONAL DE PREVENIRE, SUPRAVEGHERE ȘI CONTROL AL TUBERCULOZEI ȘI ALTOR MICOBACTERIOZE. MONITORUL OFICIAL AL ROMÂNIEI, PARTEA I, Nr. 326 bis 4.IV.2022. Available from: https://legislatie.just.ro/Public/DetaliiDocument/253597?msclkid=09174c29c24711ec95524134f8dfd6f2. Accessed October 21, 2023.
   Google Scholar
• Ministerul Sănătății. ORDIN nr. 487 din 23 martie 2020 pentru aprobarea protocolului de tratament al infecției cu virusul SARS-Cov-2. MONITORUL OFICIAL nr. 242 din 24 martie 2020. Available from: https://legislatie.just.ro/Public/DetaliiDocument/224341. Accessed October 21, 2023.
   Google Scholar
• Ministerul Sănătății. ORDIN nr. 533 din 22 aprilie 2021 privind modificarea anexei la Ordinul ministrului sănătății nr. 487/2020 pentru aprobarea protocolului de tratament al infecției cu virusul SARS-CoV-2. MONITORUL OFICIAL nr. 434 din 23 aprilie 2021. Available from: https://legislatie.just.ro/Public/DetaliiDocumentAfis/241318. Accessed October 21, 2023.
   Google Scholar
• Nukovic JA, Opancina V, Zdravkovic N, et al. Brixia Chest X-ray Score, Laboratory Parameters and Vaccination Status for Prediction of Mortality in COVID-19 Hospitalized Patients. Diagnostics (Basel). 2023;13:12. doi:10.3390/diagnostics13122122
   Google Scholar
• Au-Yong I, Higashi Y, Giannotti E, et al. Chest Radiograph Scoring Alone or Combined with Other Risk Scores for Predicting Outcomes in COVID-19. Radiology. 2022;302(2):460–469. doi:10.1148/radiol.2021210986
   PubMed Web of Science ®Google Scholar
• Little BP. Disease Severity Scoring for COVID-19: a Welcome Semiquantitative Role for Chest Radiography. Radiology. 2022;302(2):470–472. doi:10.1148/radiol.2021212212
   PubMed Web of Science ®Google Scholar
• Mousquer GT, Peres A, Fiegenbaum M. Pathology of TB/COVID-19 Co-Infection: the phantom menace. Tuberculosis (Edinb). 2021;126:102020. doi:10.1016/j.tube.2020.102020
   PubMed Web of Science ®Google Scholar
• Shariq M, Sheikh JA, Quadir N, Sharma N, Hasnain SE, Ehtesham NZ. COVID-19 and tuberculosis: the double whammy of respiratory pathogens. Eur Respir Rev. 2022;31:164. doi:10.1183/16000617.0264-2021
   Web of Science ®Google Scholar
• Feldman C, Anderson R. The role of co-infections and secondary infections in patients with COVID-19. Pneumonia (Nathan). 2021;13(1):5. doi:10.1186/s41479-021-00083-w
   PubMedGoogle Scholar
• Tadolini M, Codecasa LR, García-García JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020;56:1. doi:10.1183/13993003.01398-2020
   Web of Science ®Google Scholar
• Motta I, Centis R, D’Ambrosio L, et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology. 2020;26(4):233–240. doi:10.1016/j.pulmoe.2020.05.002
   PubMed Web of Science ®Google Scholar
• Group TC-GS. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J. 2022;59:3. doi:10.1183/13993003.02538-2021
   Web of Science ®Google Scholar
• Khurana AK, Aggarwal D. The (in)significance of TB and COVID-19 co-infection. Eur Respir J. 2020;56(2). doi:10.1183/13993003.02105-2020
   PubMedGoogle Scholar
• Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J. 2020;56:1. doi:10.1183/13993003.01708-2020
   Web of Science ®Google Scholar
• Adzic-Vukicevic T, Stosic M, Antonijevic G, Jevtic M, Radovanovic-Spurnic A, Velickovic J. Tuberculosis and COVID-19 co-infection in Serbia: pandemic challenge in a low-burden country. Front Med Lausanne. 2022;9:971008. doi:10.3389/fmed.2022.971008
   PubMed Web of Science ®Google Scholar
• Vaughn VM, Gandhi TN, Petty LA, et al. Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): a Multi-hospital Cohort Study. Clin Infect Dis. 2021;72(10):e533–e541. doi:10.1093/cid/ciaa1239
   PubMed Web of Science ®Google Scholar
• Parolina L, Pshenichnaya N, Vasilyeva I, et al. Clinical characteristics of COVID-19 in patients with tuberculosis and factors associated with the disease severity. Int J Infect Dis. 2022;124(Suppl 1):S82–S89. doi:10.1016/j.ijid.2022.04.041
   PubMedGoogle Scholar
• Song B, Sheng X, Justice JL, et al. Intercellular communication within the virus microenvironment affects the susceptibility of cells to secondary viral infections. Sci Adv. 2023;9(19):eadg3433. doi:10.1126/sciadv.adg3433
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control, WHO Regional Office for Europe. Tuberculosis Surveillance and Monitoring in Europe 2021 – 2019 Data. Copenhagen: WHO Regional Office for Europe; 2021.
   Google Scholar
• Shaweno D, Horton KC, Hayes RJ, Dodd PJ. Assortative social mixing and sex disparities in tuberculosis burden. Sci Rep. 2021;11(1):7530. doi:10.1038/s41598-021-86869-w
   PubMed Web of Science ®Google Scholar
• Bwire GM. Coronavirus: why Men are More Vulnerable to Covid-19 Than Women? SN Compr Clin. Med. 2020;2(7):874–876. doi:10.1007/s42399-020-00341-w
   Google Scholar
• Kharroubi SA, Diab-El-Harake M. Sex-differences in COVID-19 diagnosis, risk factors and disease comorbidities: a large US-based cohort study. Front Public Health. 2022;10:1029190. doi:10.3389/fpubh.2022.1029190
   PubMed Web of Science ®Google Scholar
• Peer V, Schwartz N, Green MS. Gender differences in tuberculosis incidence rates-A pooled analysis of data from seven high-income countries by age group and time period. Front Public Health. 2022;10:997025. doi:10.3389/fpubh.2022.997025
   PubMed Web of Science ®Google Scholar
• Martínez Orozco JA, Sánchez Tinajero Á, Becerril Vargas E, et al. COVID-19 and Tuberculosis Coinfection in a 51-Year-Old Taxi Driver in Mexico City. Am J Case Rep. 2020;21:e927628. doi:10.12659/AJCR.927628
   PubMed Web of Science ®Google Scholar
• Baj J, Karakuła-Juchnowicz H, Teresiński G, et al. COVID-19: specific and Non-Specific Clinical Manifestations and Symptoms: the Current State of Knowledge. J Clin Med. 2020;9:6. doi:10.3390/jcm9061753
   Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Quigley N, Gagnon S, Fortin M. Aetiology, diagnosis and treatment of moderate-to-severe haemoptysis in a North American academic centre. ERJ Open Res. 2020;6(4). doi:10.1183/23120541.00204-2020
   PubMedGoogle Scholar
• Chirana C, Vlase I. Hemopthisis in Patients with Lung Tuberculosis. ARS Medica Tomitana. 2021;27(3). doi:10.2478/arsm-2021-0025
   Google Scholar
• Kim MA, Park YE, Chong YP, Shim TS, Jo KW. Neutrophil-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio According to the Radiologic Severity of. J Korean Med Sci. 2022;37(40):e292. doi:10.3346/jkms.2022.37.e292
   PubMed Web of Science ®Google Scholar
• Sarkar S, Khanna P, Singh AK. The Impact of Neutrophil-Lymphocyte Count Ratio in COVID-19: a Systematic Review and Meta-Analysis. J Intensive Care Med. 2022;37(7):857–869. doi:10.1177/08850666211045626
   PubMed Web of Science ®Google Scholar
• Lewandowski K, Rosołowski M, Kaniewska M, et al. Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem? Pol Arch Intern Med. 2021;131(2):121–127. doi:10.20452/pamw.15715
   PubMedGoogle Scholar